Ebola Outbreak In Uganda: Groundbreaking Vaccine Trials Launched To Combat Spread

In response to new Ebola virus outbreak, the Ugandan health authorities have begun a clinical trial of administering a vaccine that can protect the people against a possible spread of this infection.

इबोला वायरस से दक्षिण अफ्रीकी देशों में अब तक 80 लोगों की मौत हो चुकी है।

Uganda has confirmed a total of 3 Ebola cases including the death of a nurse last week. In response to the outbreak, the Ugandan health authorities have begun a clinical trial of a vaccine that can protect the people against a possible spread of this infection.

In a global first, Uganda's Ministry of Health, the World Health Organization (WHO) and other partners today launched a first-ever clinical efficacy trial for a vaccine from Ebola from the Sudan species of the virus, and at an unprecedented speed for a randomized vaccine trial, in an emergency. This is the first trial to assess the clinical efficacy of a vaccine against Ebola Sudan virus disease. IAVI, the provider of the vaccine, conducted trials for safety and immunogenicity. It is also the first clinical trial of the vaccine during an outbreak.

The principal investigators from Makerere University and the Uganda Virus Research Institute (UVRI), with support from WHO and other partners, have worked tirelessly to get the trial ready in 4 days since the outbreak was confirmed on 30 January. It is the first trial to assess the clinical efficacy of a vaccine against Ebola disease due to Sudan virus. The speed was achieved through advanced research preparedness, while ensuring full compliance with national and international regulatory and ethical requirements.